The European orthopedic soft tissue solutions market is comprised of shoulder
suture anchors, knee ligament reconstruction fixation devices, knee cartilage
repair, meniscus repair devices, and rotator cuff reinforcement grafts in
France, Germany, Italy, Spain, and the UK. Revenue growth will be primarily
fuelled by increasing procedure volumes, which in turn are driven by the aging
population, increasing physical activity and participation in sports, and
supportive clinical data in some segments. The over-50 demographic is more
prone to soft tissue injuries due to degenerative conditions and as they
become more active; therefore, the rising proportion of this demographic
relative to the general population will spur procedure growth and subsequent
demand for orthopedic soft tissue solutions. Additionally, the increasing
adoption of premium-priced devices such as those made from composite materials
will positively impact average selling prices (ASPs) across the region.
Pressures on ASPs attributed to cost-containment measures in health care will,
however, serve to limit the market to some extent. Additionally, a lack of
reimbursement - often related to limited or unfavorable clinical data -
particularly in the rotator cuff reinforcement graft market, will result in
hospitals and surgeons being less likely to use these devices. Nevertheless,
the combination of the aforementioned factors will result in moderate revenue
growth over the forecast period.
METHODOLOGY
RESEARCH METHODOLOGY
This report uses a number of methodologies to gather and present data and
analysis. At the outset, a large survey of secondary sources is conducted.
These sources act as the basis for the primary research stage, which builds
and enhances the quantitative and qualitative attributes of the early research.
Secondary sources include
Government sources:
Securities and Exchange Commission filings
Food and Drug Administration and patent filings
National Center for Health Statistics data
Orthopedic soft tissue solutions companies:
Annual reports, product brochures, corporate profiles, etc.
Internal databases and reports:
Previous reports on similar/related sources
General Internet searches, medical literature, and newspaper/magazine
searches:
Identifying various centers of specialization and articles that might
provide leads for primary research
The secondary research stage builds the foundation for the primary research.
The primary research methodology has four steps:
Step 1: The first step involves an impartial scan of all the
information gathered during the secondary research stage to determine its
utility based on the specific requirements of this report. Each piece of
information is either discarded or marked as high- or low-priority and then
organized appropriately as determined by the structure and sectioning of the
report.
Step 2: At this stage, early assumptions are formed as to the
implications of the information for the various orthopedic soft tissue
solutions market segments. These assumptions are then used to determine
hypotheses using both inductive and deductive approaches. On the quantitative
front, these hypotheses result in full historical and projected market data
sets (market sizes - unit sales, average selling prices [ASPs], and revenues -
as well as market shares).
Step 3: At this stage, the research is in position for its most
important primary phase - expert interviews. Throughout the secondary research
phase, industry and medical experts are identified.
These experts are then contacted by telephone and asked to participate in
interviews on recent trends and developments in the industry. Interviews are
either conducted at the time of the initial call or scheduled at the
convenience of the expert. Interview questions are tailored to the expertise
of each particular interviewee, although in most cases, the most important
questions are asked of all experts.
The questions are largely based on the assumptions and hypotheses developed in
Step 2, which are then augmented, discarded, or adjusted based on the views
and positions put forth. Attempts are made, whenever possible, to cross-check
the views of various experts against each other and to reach positions of
consensus on issues and market numbers.
Step 4: The final stage of primary research involves individual and
group analysis by Millennium Research Group. All research results are assessed
and cross-checked thoroughly to determine their validity, relevance, and
weight. From this process, qualitative conclusions are reached and data points
finalized.
FORECAST METHODOLOGY
In addition to the research methodology outlined above, the following
“bottom-up” methodology is used to develop forecast assumptions
for the report.
A comprehensive breakdown of various orthopedic soft tissue solutions
procedures and unit sales is prepared using data from several sources,
including professional associations, government statistics, and private
research/media sources. Industry experts and practitioners are consulted to
ensure accuracy and verify observed trends. As a cross-check, total industry
revenues available through annual reports and other sources are compared
against modeled industry revenues.
Using the best estimates of industry experts, practitioners, private
research/media sources, and inhouse experts, year-by-year growth rates and
ASPs are applied individually to each subcategory to derive forecasts. These
estimates are cross-checked by industry experts (marketing managers, product
managers, CEOs, etc.) and further refined.
Overall findings are compared against market and procedure forecasts published
by other sources to ensure reasonable estimates.
Companies mentioned in this report:
Aesculap (a division of B. Braun)
Arthrex
ArthroCare
Arthro Kinetics
Biomet Sports Medicine
BioSyntech
Bio-Tissue
Carticept Medical
citieffe
co.don
ConMed Linvatec
DePuy Mitek
FH ORTHOPEDICS
Fidia Advanced Biopolymers (acquired by Anika Therapeutics)
Finceramica
Geistlich
Genzyme Biosurgery (acquired by Sanofi)
ISYS/Biovation
J. K. Orthomedic
KARL STORZ
Kensey Nash
Matricel
Orthogen
Regenerative Medical Services
SaluMedica
Smith & Nephew
Stryker
TiGenix
Tornier
Wright Medical Technology
Zimmer
Table of Contents
Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
1.0 CLINICAL LANDSCAPE
1.1. Background
1.1.1. Conditions
1.1.1.1. Osteoarthritis
1.1.1.2. Osteochondritis Dissecans
1.1.1.3. Loose Bodies
1.1.2. Injuries
1.1.2.1. Shoulder and Rotator Cuff Injuries
1.1.2.2. Knee Ligament Injuries
1.1.2.3. Knee Cartilage Injuries
1.1.2.4. Meniscus Tears
1.2. Diagnosis and Referral Patterns
1.3. Procedure Overview
1.3.1. Orthopedic Soft Tissue Procedures
1.3.1.1. Shoulder Fixation and Rotator Cuff Reinforcement
Rotator Cuff Repair
Glenohumeral Instability Repair
1.3.1.2. Knee Ligament Reconstruction
By Material
Autografts
Allografts
Other
By Anatomy
Anterior Cruciate Ligament-Only Reconstruction
Multiple Ligament Reconstruction
1.3.1.3. Knee Cartilage Repair
Debridement and Microfracture
Osteochondral Autograft Transplantation
Osteochondral Allograft Transplantation
Autologous Chondrocyte Implantation
Single-Step Procedures
Synthetic Implantation
1.3.1.4. Meniscus Repair
Meniscectomy
Meniscus Tear Repair
1.3.2. Competing Treatments
1.4. Clinical Guidelines
1.5. Country Overviews
1.5.1. France
1.5.1.1. Demographics and Economy
1.5.1.2. Health Care System
1.5.1.3. Regulatory Environment
1.5.2. Germany
1.5.2.1. Demographics and Economy
1.5.2.2. Health Care System
1.5.2.3. Regulatory Environment
1.5.3. Italy
1.5.3.1. Demographics and Economy
1.5.3.2. Health Care System
1.5.3.3. Regulatory Environment
1.5.4. Spain
1.5.4.1. Demographics and Economy
1.5.4.2. Health Care System
1.5.4.3. Regulatory Environment
1.5.5. UK
1.5.5.1. Demographics and Economy
1.5.5.2. Health Care System
1.5.5.3. Regulatory Environment
1.5.6 Standardization of Advanced Medical Therapy Medicinal Products in
the European Union
European Markets for Orthopedic Soft Tissue Solutions 2012 published by Millennium Research Group in March 31, 2012. This report price starts from US $ 6195.
The contents of this page may be different from the latest version. Please contact us for details.
Press Release
European Soft Tissue Solutions Market Close to $320 Million by 2016, Premium-Priced Devices Support Revenues
May 22nd, 2012
Global Information Inc. would like to present a new market research report, "European Markets for Orthopedic Soft Tissue Solutions 2012" by Millennium Research Group.
Despite downward pricing pressures from poor economies and tight healthcare reimbursement, rising procedure volumes will enable the European soft tissue solutions market to grow to a value of nearly $320 million by 2016.
The orthopedic soft tissue solutions market is largely driven by elective procedures, so the negative impact of economic conditions on household disposable income has a strong effect on growth and will continue to limit the market through 2016. However, the growing over-50 population, with its increased susceptibility to degenerative conditions, will be the primary driver of procedure volumes and combined with factors such as increasing levels of obesity and increasing participation in sports, will ensure that procedure volumes continue to grow.
The overall market will be supported by several high-growth segments. For example, Europe-wide approval for premium-priced autologous chondrocyte implantation, mediated by the European Medicines Agencys standardized regulatory framework for tissue-engineered products, set to take effect in 2013, will encourage penetration of these products and is expected to boost the knee cartilage repair segment of the market through 2016.
In addition, arthroscopic techniques, which result in less patient pain and faster recovery times and therefore will encourage people to seek treatment for injuries, are becoming increasingly available in Europe and newer surgeons are likely to receive training to perform surgeries using these techniques.
"While there is continued downward pressure on average selling prices by cash-strapped healthcare facilities and patients, the growing adoption of premium-priced devices such as resorbable shoulder suture anchors and composite interference screws will support revenue growth," said MRG Analyst Rene Azeez. "Shoulder suture anchors and knee ligament reconstruction devices will be the two largest revenue segments in the European orthopedic soft tissue solutions market through 2016. The growing adoption of premium-priced devices in those segments will thus have a strong stimulating effect on the market overall."
Millennium Research Groups European Markets for Orthopedic Soft Tissue Solutions 2012 report includes procedure, unit, average selling price and revenue information, along with market drivers and limiters and competitive landscape for shoulder suture anchors, knee ligament reconstruction devices, knee cartilage repair devices, meniscus repair devices, and rotator cuff reinforcement grafts sold in France, Germany, Italy, Spain and the United Kingdom.
